Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status

This publication has 26 references indexed in Scilit:

• Possible Mechanism of Hematocrit Elevation by Sodium Glucose Cotransporter 2 Inhibitors and Associated Beneficial Renal and Cardiovascular Effects
  Circulation, 2019
• Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
  JACC, 2019
• SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
  The Lancet, 2019
• Effects of the sodium‐glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan
  Nephrology, 2018
• Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload
  Journal of Clinical Investigation, 2018
• Sirtuins and NAD ⁺ in the Development and Treatment of Metabolic and Cardiovascular Diseases
  Circulation Research, 2018
• High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection
  Scientific Reports, 2018
• How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
  Diabetes Care, 2017
• Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium
  American Journal of Physiology-Heart and Circulatory Physiology, 2007
• Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
  Nature, 2005